No profile data available.
Baiyunshan PH (GZPHF) is a healthcare company in the various medical supply wholesale industry, based in Guangzhou, China, with about 26,365 full-time employees.
It reported revenue of 77.66 billion CNY for fiscal year 2025, up 3.6% from fiscal year 2024, and net income of 2.98 billion CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 23.28 billion CNY, up 3.6% from a year before. Its market capitalization was $3.48 billion as of February 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of February 5, 2026.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments.
Baiyunshan PH reported 77.66 billion CNY in revenue for fiscal year 2025, up 3.6% from 74.99 billion CNY in fiscal year 2024. In Q1 2026 revenue was 23.28 billion CNY.
$3.48 billion as of February 5, 2026.
Listed companies of a similar size in the same industry (various medical supply wholesale) include Avantor, Inc. (AVTR), M1 Kliniken AG (MKLNF), Euro Tech Holdings Company Limited (CLWT).